A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction

Clinical trial NCT07082452 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07082452
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, B-Cell, Chronic Leukemia

Start date: 2025-09-01
Primary completion: 2030-09-01
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.